Effect of topiramate on intractable seizures in Taiwanese children

Sung Tse Li, Ein Yiao Shen, Nan Chang Chiu, Che Sheng Ho

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We performed a prospective study to evaluate the effect of topiramate as an adjunctive therapy in Taiwanese children with intractable partial epilepsy and generalized epilepsy. Thirty children aged from 2 to 16 years (8.5 ± 3.8 years) were enrolled in this study. Eighteen children (60.0%) had partial epilepsy, and 12 children (40.0%) had generalized epilepsy. These children were experiencing more than one seizure per month even under a stable antiepileptic regimen treatment. Topiramate was begun at 1 mg/kg·day, and the dosage was raised by 1 mg/kg·day each week. Titration continued for 4 weeks or more. The maximal dosage was 10 mg/kg·day. In children with partial epilepsy, six children (33.3%) achieved ≥ 50% frequency reduction, while eight children (44.4%) achieved a seizure-free state. In children with generalized epilepsy, including infantile spasms, four children (33.3%) achieved ≥ 50% frequency reduction, while five children (41.7%) achieved a seizure-free state. The most common adverse effect was poor appetite (10.0%). No idiosyncratic reactions to topiramate were found. Only one patient discontinued topiramate because of central hyperventilation. Topiramate can be used as an adjunctive antiepileptic drug for intractable epileptic children in Taiwan.

Original languageEnglish
Pages (from-to)59-63
Number of pages5
JournalActa Neurologica Taiwanica
Volume13
Issue number2
Publication statusPublished - Jun 2004

Fingerprint

Seizures
Generalized Epilepsy
Partial Epilepsy
Anticonvulsants
topiramate
Infantile Spasms
Hyperventilation
Appetite
Taiwan
Prospective Studies
Therapeutics

Keywords

  • Children
  • Epileptic therapy
  • Intractable epilepsy
  • Topiramate

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Li, S. T., Shen, E. Y., Chiu, N. C., & Ho, C. S. (2004). Effect of topiramate on intractable seizures in Taiwanese children. Acta Neurologica Taiwanica, 13(2), 59-63.

Effect of topiramate on intractable seizures in Taiwanese children. / Li, Sung Tse; Shen, Ein Yiao; Chiu, Nan Chang; Ho, Che Sheng.

In: Acta Neurologica Taiwanica, Vol. 13, No. 2, 06.2004, p. 59-63.

Research output: Contribution to journalArticle

Li, ST, Shen, EY, Chiu, NC & Ho, CS 2004, 'Effect of topiramate on intractable seizures in Taiwanese children', Acta Neurologica Taiwanica, vol. 13, no. 2, pp. 59-63.
Li, Sung Tse ; Shen, Ein Yiao ; Chiu, Nan Chang ; Ho, Che Sheng. / Effect of topiramate on intractable seizures in Taiwanese children. In: Acta Neurologica Taiwanica. 2004 ; Vol. 13, No. 2. pp. 59-63.
@article{228b1aa375c44647a63a37cb10cbbc18,
title = "Effect of topiramate on intractable seizures in Taiwanese children",
abstract = "We performed a prospective study to evaluate the effect of topiramate as an adjunctive therapy in Taiwanese children with intractable partial epilepsy and generalized epilepsy. Thirty children aged from 2 to 16 years (8.5 ± 3.8 years) were enrolled in this study. Eighteen children (60.0{\%}) had partial epilepsy, and 12 children (40.0{\%}) had generalized epilepsy. These children were experiencing more than one seizure per month even under a stable antiepileptic regimen treatment. Topiramate was begun at 1 mg/kg·day, and the dosage was raised by 1 mg/kg·day each week. Titration continued for 4 weeks or more. The maximal dosage was 10 mg/kg·day. In children with partial epilepsy, six children (33.3{\%}) achieved ≥ 50{\%} frequency reduction, while eight children (44.4{\%}) achieved a seizure-free state. In children with generalized epilepsy, including infantile spasms, four children (33.3{\%}) achieved ≥ 50{\%} frequency reduction, while five children (41.7{\%}) achieved a seizure-free state. The most common adverse effect was poor appetite (10.0{\%}). No idiosyncratic reactions to topiramate were found. Only one patient discontinued topiramate because of central hyperventilation. Topiramate can be used as an adjunctive antiepileptic drug for intractable epileptic children in Taiwan.",
keywords = "Children, Epileptic therapy, Intractable epilepsy, Topiramate",
author = "Li, {Sung Tse} and Shen, {Ein Yiao} and Chiu, {Nan Chang} and Ho, {Che Sheng}",
year = "2004",
month = "6",
language = "English",
volume = "13",
pages = "59--63",
journal = "Acta Neurologica Taiwanica",
issn = "1019-6099",
publisher = "Taiwan Neurological Society",
number = "2",

}

TY - JOUR

T1 - Effect of topiramate on intractable seizures in Taiwanese children

AU - Li, Sung Tse

AU - Shen, Ein Yiao

AU - Chiu, Nan Chang

AU - Ho, Che Sheng

PY - 2004/6

Y1 - 2004/6

N2 - We performed a prospective study to evaluate the effect of topiramate as an adjunctive therapy in Taiwanese children with intractable partial epilepsy and generalized epilepsy. Thirty children aged from 2 to 16 years (8.5 ± 3.8 years) were enrolled in this study. Eighteen children (60.0%) had partial epilepsy, and 12 children (40.0%) had generalized epilepsy. These children were experiencing more than one seizure per month even under a stable antiepileptic regimen treatment. Topiramate was begun at 1 mg/kg·day, and the dosage was raised by 1 mg/kg·day each week. Titration continued for 4 weeks or more. The maximal dosage was 10 mg/kg·day. In children with partial epilepsy, six children (33.3%) achieved ≥ 50% frequency reduction, while eight children (44.4%) achieved a seizure-free state. In children with generalized epilepsy, including infantile spasms, four children (33.3%) achieved ≥ 50% frequency reduction, while five children (41.7%) achieved a seizure-free state. The most common adverse effect was poor appetite (10.0%). No idiosyncratic reactions to topiramate were found. Only one patient discontinued topiramate because of central hyperventilation. Topiramate can be used as an adjunctive antiepileptic drug for intractable epileptic children in Taiwan.

AB - We performed a prospective study to evaluate the effect of topiramate as an adjunctive therapy in Taiwanese children with intractable partial epilepsy and generalized epilepsy. Thirty children aged from 2 to 16 years (8.5 ± 3.8 years) were enrolled in this study. Eighteen children (60.0%) had partial epilepsy, and 12 children (40.0%) had generalized epilepsy. These children were experiencing more than one seizure per month even under a stable antiepileptic regimen treatment. Topiramate was begun at 1 mg/kg·day, and the dosage was raised by 1 mg/kg·day each week. Titration continued for 4 weeks or more. The maximal dosage was 10 mg/kg·day. In children with partial epilepsy, six children (33.3%) achieved ≥ 50% frequency reduction, while eight children (44.4%) achieved a seizure-free state. In children with generalized epilepsy, including infantile spasms, four children (33.3%) achieved ≥ 50% frequency reduction, while five children (41.7%) achieved a seizure-free state. The most common adverse effect was poor appetite (10.0%). No idiosyncratic reactions to topiramate were found. Only one patient discontinued topiramate because of central hyperventilation. Topiramate can be used as an adjunctive antiepileptic drug for intractable epileptic children in Taiwan.

KW - Children

KW - Epileptic therapy

KW - Intractable epilepsy

KW - Topiramate

UR - http://www.scopus.com/inward/record.url?scp=3042794749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042794749&partnerID=8YFLogxK

M3 - Article

C2 - 15478676

AN - SCOPUS:3042794749

VL - 13

SP - 59

EP - 63

JO - Acta Neurologica Taiwanica

JF - Acta Neurologica Taiwanica

SN - 1019-6099

IS - 2

ER -